CJC-1295 (No DAC), GHRP-6 10mg (Blend)

Peptide Science research editorial team.

CJC-1295 No DAC plus GHRP-6 10mg Blend Overview

CJC-1295 No DAC plus GHRP-6 10mg Blend from Peptide Science is a dual-active lyophilised vial pairing a 30-amino-acid modified GHRH analogue (CJC-1295 without the Drug Affinity Complex) with a 6-amino-acid ghrelin-receptor agonist (GHRP-6). The blend supplies one of the most-cited pathway-comparison combinations in preclinical pituitary research, where a GHRH analogue and a GHRP are often co-administered to observe additive effects on growth-hormone secretion in cultured somatotrophs.

GH-Axis Mechanism Context

CJC-1295 binds the GHRH receptor on the surface of pituitary somatotrophs and triggers adenylate cyclase activity, raising intracellular cAMP. GHRP-6 binds the GHS-R1a ghrelin receptor and acts through a separate phospholipase-C pathway. Because the two receptors converge on the same final secretory step (growth hormone release), combined research administration is the standard model for studying additive secretagogue activity in cell-culture work. The “No DAC” designation indicates the absence of the maleimidopropionic-acid Drug Affinity Complex used in the longer-acting CJC-1295 DAC variant, giving this version a shorter in-vitro half-life. Browse the broader growth-hormone peptide range for related compounds.

Specifications

Reconstitution and Handling

The lyophilised dual-active vial is typically reconstituted with bacteriostatic water for stability and assay-concentration studies. For laboratories preferring the Ipamorelin pairing (which has been characterised for selective GH-release in preclinical models with reported low cortisol and prolactin response), see CJC-1295 No DAC plus Ipamorelin 10mg Blend.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent for each active, with mass-spectrometry confirmation. A signed Certificate of Analysis ships with every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging. For the single-compound GHRH analogue alone, see Sermorelin 2mg, the 29-amino-acid bioactive fragment of native GHRH.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws. Lyophilised vials store at 2 to 8 degrees Celsius; protect from light.